Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2013 - 2026)
Thermo Fisher Scientific's (TMO) quarterly Income from Non-Controlling Interests came in at $5.0 million in Q2 2026, up 150.0% on a YoY basis from $2.0 million in Q2 2025, and little changed quarter-over-quarter from $5.0 million in Q1 2026.
Analysis
Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends
Thermo Fisher Scientific (TMO) has reported Income from Non-Controlling Interests for 9 consecutive years, with $5.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income from Non-Controlling Interests rose 150.0% year-over-year to $5.0 million; the trailing twelve-month figure through Jun 2026 stood at $21.0 million (changed N/A YoY), and the FY2025 full-year result was $17.0 million, up 466.67% from the prior year.
- Income from Non-Controlling Interests was little changed at $5.0 million in Q2 2026 per TMO's latest filing, from $5.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $6.0 million in Q2 2024 and bottomed at -$24.0 million in Q4 2023.
- Historically, Income from Non-Controlling Interests has averaged $58823.5 across 5 years, with a median of $4.0 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Income from Non-Controlling Interests plunged 1100.0% in 2023, then jumped 500.0% in 2024.
- Over 5 years, Income from Non-Controlling Interests stood at -$2.0 million in 2022, then slumped by 1100.0% to -$24.0 million in 2023, then soared by 75.0% to -$6.0 million in 2024, then jumped by 200.0% to $6.0 million in 2025, then decreased by 16.67% to $5.0 million in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $5.0 million, $5.0 million, and $6.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 1.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 5.00 Mn |
| Mar 28, 2026 | 5.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 27, 2025 | 5.00 Mn |
| Jun 28, 2025 | 2.00 Mn |
| Mar 29, 2025 | 4.00 Mn |
| Dec 31, 2024 | -6.00 Mn |
| Jun 29, 2024 | 6.00 Mn |
| Mar 30, 2024 | 4.00 Mn |
| Dec 31, 2023 | -24.00 Mn |
| Sep 30, 2023 | -20.00 Mn |
| Jul 1, 2023 | 1.00 Mn |
| Apr 1, 2023 | 3.00 Mn |
| Dec 31, 2022 | -2.00 Mn |
| Oct 1, 2022 | 3.00 Mn |
| Jul 2, 2022 | 4.00 Mn |
| Apr 2, 2022 | 5.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Oct 2, 2021 | 1.00 Mn |
| Jul 3, 2021 | 1.00 Mn |